Beyond Diagnosis: Managing the Glioma Case

In a recent immunotherapy trial for canine high-grade glioma, French bulldogs had significantly shorter survival than boxers and Boston terriers — highlighting meaningful breed-linked differences in tumor biology and treatment response. Dr. Susan Arnold examines what those findings may tell us about glioma across breeds and translates the research into clinical decision-making around suspicion, diagnostic workup, prognosis framing, and referral.

In a clinical trial investigating immunotherapy-based treatments for pet dogs with high-grade glioma, a concerning pattern emerged: French bulldogs had markedly worse survival than all other breeds, including closely related breeds. Board-certified neurologist (DACVIM — Neurology) Dr. Susan Arnold provides a summary of canine high-grade glioma, the methods used to investigate this survival disparity, and the results of the investigations. Listeners will also gain an understanding of translational research. Presented through Vet On It's sponsor-free platform — no pharmaceutical influence on content or recommendations.